International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2018 - Volume 22, Number 2
View All Articles in Issue

Page(s): 92

PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Page 1

Download in electronic PDF format for $75

Abstract:

Related Keywords: Loyd V. Allen Jr., PhD, RPh, DQSA, U.S. House of Representatives Energy and Commerce Committee, Subcommittee on Health, Examining Implementation of the Compounding Quality Act, U.S. Food and Drug Administration, FDA, pharmacy compounding oversight and regulation, office-use compounding, Pharmacy Compounding Advisory Committee, PCAC, dietary supplements, CGMP standards, Guidance for Industry documents, HR2871

Related Categories: LEGAL, PROFESSIONAL ISSUES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Allen Loyd V Jr	Mar/Apr 2018 Pg. 92
IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing Blankenship Cynthia	Mar/Apr 2018 Pg. 125-126
Standing Together Fixing the Drug Quality and Security Act Miller David G	Mar/Apr 2015 Pg. 104-106
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr	Sep/Oct 2015 Pg. 389-390
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
Applying Quality of Design Concepts to Pharmacy Compounding Timko Robert J	Nov/Dec 2015 Pg. 453-463
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Miller David G	Jan/Feb 2014 Pg. 35-36
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
PreScription: Déjà Vu All Over Again Allen Loyd V Jr	May/Jun 2014 Pg. 180
The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871 Rice Baylor	Jul/Aug 2017 Pg. 290-291
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Allen Loyd V Jr	Jul/Aug 2007 Pg. 350-351
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Pore R David	Nov/Dec 2012 Pg. 446-450
Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds Trusley Craig	Nov/Dec 2007 Pg. 487-490
Quality-Control Analytical Methods: Glossary of Quality Control/Quality Assurance Terms in Pharmaceutical Compounding Kupiec Thomas C, Okeke Claudia, Allen Loyd V Jr, Denison Clay	Jul/Aug 2005 Pg. 300-302
Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996 Allen Loyd V Jr	Jan/Feb 2008 Pg. 63
PreScription: 2014 in Review Allen Loyd V Jr	Jan/Feb 2015 Pg. 4
The International Academy of Compounding Pharmacists Introduces a New President Rice Baylor	Mar/Apr 2017 Pg. 116-117
Return to Top